Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study.

Saved in:
Bibliographic Details
Title: Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study.
Authors: Novy E; Faculty of Medicine, University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland , Brisbane, Queensland, Australia.; Université de Lorraine, SIMPA , Nancy, France.; Departement of anesthesiology, Critical care and peri-operative medicine, University hospital of Nancy , Nancy, France., Abdul-Aziz MH; Faculty of Medicine, University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland , Brisbane, Queensland, Australia., Cheng V; Faculty of Medicine, University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland , Brisbane, Queensland, Australia., Burrows F; Department of Pharmacy, St. Vincent's Hospital , Sydney, New South Wales, Australia., Buscher H; Department of Intensive Care Medicine, St. Vincent's Hospital , Sydney, New South Wales, Australia.; University of New South Wales, St Vincent's Centre for Applied Medical Research , Sydney, New South Wales, Australia., Corley A; The Prince Charles Hospital, Critical Care Research Group and Adult Intensive Care Services , Brisbane, Queensland, Australia., Diehl A; Department of Intensive Care and Hyperbaric Medicine, The Alfred Hospital and School of Public Health and Preventive Medicine, Monash University , Melbourne, Victoria, Australia., Gilder E; Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital , Auckland, New Zealand., Levkovich BJ; Experiential Development and Graduate Education and Centre for Medicines Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Melbourne, Victoria, Australia., McGuinness S; Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital , Auckland, New Zealand., Ordonez J; Faculty of Medicine, University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland , Brisbane, Queensland, Australia., Parke R; Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital , Auckland, New Zealand.; The University of Auckland, School of Nursing , Auckland, New Zealand., Parker S; Faculty of Medicine, University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland , Brisbane, Queensland, Australia., Pellegrino V; Department of Intensive Care and Hyperbaric Medicine, The Alfred Hospital and School of Public Health and Preventive Medicine, Monash University , Melbourne, Victoria, Australia., Reynolds C; Department of Intensive Care Medicine, St. Vincent's Hospital , Sydney, New South Wales, Australia., Rudham S; Department of Intensive Care Medicine, St. Vincent's Hospital , Sydney, New South Wales, Australia., Wallis SC; Faculty of Medicine, University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland , Brisbane, Queensland, Australia., Welch SA; Department of Pharmacy, St. Vincent's Hospital , Sydney, New South Wales, Australia., Fraser JF; The Prince Charles Hospital, Critical Care Research Group and Adult Intensive Care Services , Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland , Brisbane, Queensland, Australia.; Faculty of Health, Queensland University of Technology , Brisbane, Queensland, Australia.; Faculty of Health Sciences and Medicine, Bond University , Gold Coast, Queensland, Australia., Shekar K; The Prince Charles Hospital, Critical Care Research Group and Adult Intensive Care Services , Brisbane, Queensland, Australia.; Faculty of Health, Queensland University of Technology , Brisbane, Queensland, Australia.; Faculty of Health Sciences and Medicine, Bond University , Gold Coast, Queensland, Australia., Roberts JA; Faculty of Medicine, University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland , Brisbane, Queensland, Australia.; Department of Intensive Care Medicine and Pharmacy, Royal Brisbane and Women's Hospital , Brisbane, Queensland, Australia.; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier , Nîmes, France.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jan 10; Vol. 68 (1), pp. e0120123. Date of Electronic Publication: 2023 Dec 08.
Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-6596
DOI:10.1128/aac.01201-23